SCHEMBL25754153

SCHEMBL25754153

CSS[C@@H](C)C[C@@H]1C[C@H](n2ncc3c(=O)[nH]c(N)nc32)O[C@@H]1COP(=O)(O)OP(=O)(O)OP(=O)(O)O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 2/20 0.40
▸ P2RY6 Q15077 4/20 0.39
▸ P2RY2 P41231 4/20 0.39
▸ P2RY4 P51582 3/20 0.39
▸ POLA1 P09884 1/20 0.38
▸ POLD1 P28340 1/20 0.38
▸ FUT5 Q11128 1/20 0.38
▸ TK1 P04183 2/20 0.37
▸ KRAS P01116 2/20 0.37
▸ TGM2 P21980 1/20 0.37
▸ ENTPD1 P49961 1/20 0.36
▸ DTYMK P23919 2/20 0.36
▸ ENPP1 P22413 2/20 0.36
▸ P2RY1 P47900 2/20 0.36
▸ P2RX1 P51575 1/20 0.36
▸ P2RX3 P56373 1/20 0.36
▸ P2RY11 Q96G91 1/20 0.36
▸ P2RX4 Q99571 1/20 0.36
▸ POLG P54098 1/20 0.36
▸ P2RY12 Q9H244 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24973050 1.00 POLB (0.40) POLBP2RY6P2RY2P2RY4POLA1
SCHEMBL25767949 1.00 POLB (0.40) POLBP2RY6P2RY2P2RY4POLA1
SCHEMBL25754160 0.87 POLB (0.40) POLBP2RY6P2RY2P2RY4POLA1
SCHEMBL24971056 0.87 POLB (0.40) POLBP2RY6P2RY2P2RY4POLA1
SCHEMBL25767990 0.87 POLB (0.40) POLBP2RY6P2RY2P2RY4POLA1
SCHEMBL31753101 0.83 POLB (0.56) POLBP2RY6P2RY2P2RY4FUT5
SCHEMBL22327363 0.72 POLB (0.58) POLBP2RY6P2RY2P2RY4FUT5
SCHEMBL22327359 0.72 POLB (0.58) POLBP2RY6P2RY2P2RY4FUT5
SCHEMBL26068898 0.72 POLB (0.58) POLBP2RY6P2RY2P2RY4FUT5
SCHEMBL26068895 0.72 POLB (0.58) POLBP2RY6P2RY2P2RY4FUT5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230203083-A1 NUCLEOTIDE ANALOGUES FIRST-CITIZENS BANK & TRUST COMPANY 2023-06-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230203083-A1 NUCLEOTIDE ANALOGUES ITPA, POLB, NUDT1 POLB 2/4885P2RY6 948/4885P2RY2 1336/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback